Scholarlink

<p>With increasing age, mares are frequently affected by endometrial fibrosis. Transforming growth factor beta 1 (TGF-β1) promotes fibrosis, while milk fat globule EGF and factor V/VIII domain containing (MFGE8) primarily exerts antifibrotic effects. We used in situ hybridization analysis (ISH) to investigate <i>MFGE8</i>, <i>TGFB1</i> and its downstream effectors cellular communication network factor 2 (<i>CCN2</i>) and transgelin (<i>TAGLN</i>) in equine endometrial fibrosis. Additionally, transcriptional effects of TGF-β1 and MFGE8 on equine endometrial fibroblasts in vitro were investigated by single cell sequencing. Fibrotic areas overexpressing <i>TGFB1</i> displayed increased <i>CCN2</i> and <i>TAGLN</i> expression. The vast majority of glandular areas overexpressing <i>MFGE8</i> were affected by fibrosis, confirming its relevance in equine endometrial fibrosis. Single cell sequencing following TGF-β1 exposure of fibroblasts confirmed its profibrotic effects. MFGE8 treatment effects were subtler, including decreased profibrotic leukemia inhibitory factor expression and an upregulation of interferon alpha and beta signaling in a subset of cells. In a fibroblast subpopulation, upregulation of phosphatase and tensin homolog signaling, indicated an antifibrotic effect of MFGE8. In conclusion, our study reaffirms the profibrotic effects of TGF-β1 and highlights MFGE8 as a novel player in equine endometrial fibrosis with our results suggesting an antifibrotic effect of MFGE8.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Milk fat globule EGF and factor V/VIII domain containing (MFGE8) as a novel player in equine endometrial fibrosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月9日

查看全文
  • Elena zu Klampen,
  • Gregor Neufeld,
  • Claudia Klein

摘要

With increasing age, mares are frequently affected by endometrial fibrosis. Transforming growth factor beta 1 (TGF-β1) promotes fibrosis, while milk fat globule EGF and factor V/VIII domain containing (MFGE8) primarily exerts antifibrotic effects. We used in situ hybridization analysis (ISH) to investigate MFGE8, TGFB1 and its downstream effectors cellular communication network factor 2 (CCN2) and transgelin (TAGLN) in equine endometrial fibrosis. Additionally, transcriptional effects of TGF-β1 and MFGE8 on equine endometrial fibroblasts in vitro were investigated by single cell sequencing. Fibrotic areas overexpressing TGFB1 displayed increased CCN2 and TAGLN expression. The vast majority of glandular areas overexpressing MFGE8 were affected by fibrosis, confirming its relevance in equine endometrial fibrosis. Single cell sequencing following TGF-β1 exposure of fibroblasts confirmed its profibrotic effects. MFGE8 treatment effects were subtler, including decreased profibrotic leukemia inhibitory factor expression and an upregulation of interferon alpha and beta signaling in a subset of cells. In a fibroblast subpopulation, upregulation of phosphatase and tensin homolog signaling, indicated an antifibrotic effect of MFGE8. In conclusion, our study reaffirms the profibrotic effects of TGF-β1 and highlights MFGE8 as a novel player in equine endometrial fibrosis with our results suggesting an antifibrotic effect of MFGE8.